Skip to main content
Kamran Qureshi, MD, Gastroenterology, Saint Louis, MO

Kamran Qureshi MD

Hepatology & Liver Transplantation


Associate Professor of Medicine

Join to View Full Profile
  • 1225 S Grand BlvdFl 3Saint Louis, MO 63104

  • Phone+1 314-977-2140

  • Fax+1 314-977-1660

Dr. Qureshi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • I treat patients for a range of liver diseases, including autoimmune liver disease, liver cancer, cirrhosis, and infectious hepatitis. I perform screening endoscopic procedures and manage liver transplantations.

    My research interests include liver cirrhosis, portal hypertension, and liver cancer.

Education & Training

  • AdventHealth Florida
    AdventHealth FloridaFellowship, Gastroenterology, 2014
  • Carle Foundation Hospital
    Carle Foundation HospitalResidency, Internal Medicine, 2008 - 2011
  • King Edward Medical University
    King Edward Medical UniversityClass of 2004

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2011 - 2026
  • MO State Medical License
    MO State Medical License 2018 - 2026
  • PA State Medical License
    PA State Medical License 2013 - 2018
  • FL State Medical License
    FL State Medical License 2011 - 2017
  • Gastroenterology
    American Board of Internal Medicine Gastroenterology
  • Obesity Medicine
    American Board of Obesity Medicine Obesity Medicine

Awards, Honors, & Recognition

  • Excellence in teaching Award Frank Burton, 2021
  • Poster presentation of distinction ACG Annual Meeting, 2021
  • Presidential Poster Award ACG Annual Scientific Meeting, 2019
  • Join now to see all

Publications & Presentations

PubMed

Authored Content

  • Asymptomatic Hepatic Leiomyoma in an Immunocompetent Middle-Aged WomanNovember 2022
  • Secondary Treatment of Primary Biliary Cholangitis: Early Prediction of Inadequate Response to Ursodeoxycholic Acid in Patients with PBC.September 2022
  • The molecular basis for current targets of NASH therapiesFebruary 2020
  • Hepatitis C Treatment Differences in Elderly Patients: Single-Center Retrospective StudyFebruary 2020
  • Join now to see all

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: